While revenues for the period rose 4.5 percent to total $1.6 billion, expenses soared 8.7 percent to total $1.8 billion. Every category of expenses increased for the four-acute-care hospital system, with salaries and benefits rising 5.6 percent to reach $841.2 million.
In December, Main Line Health received a credit rating downgrade to “A1” from “Aa3,” reflecting a multiyear trend of weak operating performance and expectations of tepid progress, Moody’s said. The system’s long-term debt stood at $626 million as of March 31.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
